Patents by Inventor Lonnie Bookbinder

Lonnie Bookbinder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reagents and Methods for Treating Cancer
    Publication number: 20160362693
    Abstract: This invention describes a genetic system for targeting the EVI1 gene in mammalian cells. The EVI1 gene is an oncogenic transcription factor that, when expressed, accelerates cell division and inhibits death of cells. Nucleotide sequences that block the expression of EVI1 and drug delivery systems for them are described. These nucleotide sequences cause a block in cell growth and division and trigger death of mammalian cells, including lung and ovarian cancer cells.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 15, 2016
    Inventors: Thomas Primiano, Lonnie Bookbinder, Bey-Dih Chang, Jeremy Heidel
  • Reagents and methods for treating cancer
    Patent number: 9273316
    Abstract: This invention describes a genetic system for targeting the EVI1 gene in mammalian cells. The EVI1 gene is an oncogenic transcription factor that, when expressed, accelerates cell division and inhibits death of cells. Nucleotide sequences that block the expression of EVI1 and drug delivery systems for them are described. These nucleotide sequences cause a block in cell growth and division and trigger death of mammalian cells, including lung and ovarian cancer cells.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: March 1, 2016
    Assignee: PeptiMed, Inc.
    Inventors: Thomas Primiano, Lonnie Bookbinder, Bey-Dih Chang, Jeremy Heidel
  • Reagents and Methods for Treating Cancer
    Publication number: 20110293698
    Abstract: This invention describes a genetic system for targeting the EVI1 gene in mammalian cells. The EVI1 gene is an oncogenic transcription factor that, when expressed, accelerates cell division and inhibits death of cells. Nucleotide sequences that block the expression of EVI1 and drug delivery systems for them are described. These nucleotide sequences cause a block in cell growth and division and trigger death of mammalian cells, including lung and ovarian cancer cells.
    Type: Application
    Filed: May 23, 2011
    Publication date: December 1, 2011
    Applicant: NanoOncology, Inc.
    Inventors: Thomas Primiano, Lonnie Bookbinder, Bey-Dih Chang, Jeremy Heidel